Drawing for IMMUNOZYME

USPTO serial 79262100

IMMUNOZYME

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
MESSICK, TABITHA LEE
Law office
TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IMMUNOZYME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

George A. Smith, Jr.

George A. Smith, Jr. HOWSON & HOWSON LLP325 Sentry ParkwaySuite 160, 5 Sentry EastBLUE BELL, PA 19422

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and medicinal preparations and substances for immune upregulation; nutritional supplements; immune system nutritional supplements; enzyme formulations for medical use; enzyme formulations for nutritional and health care purposes; enzyme dietary supplements; medicated preparations and products, namely, immune products; nutritional supplements, namely, probiotic bacterial formulations for medical use; food supplements containing probiotics; food supplements containing vitamin supplements; food supplements containing minerals; food supplements containing mineral supplements; food preparations being nutritional and dietary supplements in crystalline, granular, solid bar and powder form; pharmaceutical and medicinal preparations and substances in the nature of enzyme formulations for immune enhancement; pharmaceutical and medicinal preparations and substances derived from dried mushrooms; pharmaceutical and medicinal preparations and substances derived from preserved mushrooms for upregulated immune function; pharmaceutical and medicinal preparations and substances derived from fermented mushrooms for upregulated immune function; dietetic substances, in the nature of ingestive products, adapted for medical use; vitamins and vitamin supplements; dietary and nutritional ingestive immune products and supplements; dietary and nutritional products and supplements, namely, mushrooms and mushroom extracts; pharmaceutical and medicinal preparations in the nature of digestive enzyme formulations; mineral nutritional supplementsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 4, 2021FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 14, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 14, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 26, 2020OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 9, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 9, 2020OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 14, 2020MAB1ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT—
Sep 14, 2020ABN1ABANDONMENT - EXPRESS MAILED—
Sep 12, 2020EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Sep 12, 2020GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Sep 12, 2020GNSIINQUIRY TO SUSPENSION E-MAILED—
Sep 12, 2020CNSISUSPENSION INQUIRY WRITTEN—
May 29, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 29, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 29, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 29, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 29, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 29, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 29, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 10, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 10, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Mar 10, 2020CNSLSUSPENSION LETTER WRITTEN—
Feb 27, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 27, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 27, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 26, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 26, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 26, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Feb 26, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 26, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 26, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 13, 2019RFNTREFUSAL PROCESSED BY IB—
Aug 27, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 27, 2019RFRRREFUSAL PROCESSED BY MPU—
Aug 3, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 2, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 31, 2019DOCKASSIGNED TO EXAMINER—
Jul 16, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 10, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 4, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance